Cal. Code Regs. tit. 16 § 1782

Current through Register 2024 Notice Reg. No. 40, October 4, 2024
Section 1782 - Reporting Sales of Drugs Subject to Abuse

Each manufacturer, wholesaler, and third-party logistics provider shall report to the Board or its designee, up to twelve (12) times a year, all sales of dangerous drugs subject to abuse as designated by the Board for reporting, in excess of amounts to be determined by the Board from time to time. Reports shall be made within thirty (30) days of the request in the form specified by the Board.

Cal. Code Regs. Tit. 16, § 1782

1. New section filed 3-31-78 as an emergency; effective upon filing (Register 78, No. 13). For history of former Section 1782, see Register 71, No. 26.
2. Repealed by operation of Section 11422.1(c), Government Code (Register 78, No. 14).
3. New section filed 10-13-78; effective thirtieth day thereafter (Register 78, No. 41).
4. Amendment filed 3-8-84; effective thirtieth day thereafter (Register 84, No. 10).
5. Change without regulatory effect amending NOTE filed 9-11-2002 pursuant to section 100, title 1, California Code of Regulations (Register 2002, No. 37).
6. Amendment of section and NOTE filed 2-22-2021; operative 4-1-2021 (Register 2021, No. 9).

Note: Authority cited: Section 4005, Business and Professions Code. Reference: Sections 4081, 4164, 4165 and 4332, Business and Professions Code.

1. New section filed 3-31-78 as an emergency; effective upon filing (Register 78, No. 13). For history of former Section 1782, see Register 71, No. 26.
2. Repealed by operation of Section 11422.1(c), Government Code (Register 78, No. 14).
3. New section filed 10-13-78; effective thirtieth day thereafter (Register 78, No. 41).
4. Amendment filed 3-8-84; effective thirtieth day thereafter (Register 84, No. 10).
5. Change without regulatory effect amending Note filed 9-11-2002 pursuant to section 100, title 1, California Code of Regulations (Register 2002, No. 37).
6. Amendment of section and Note filed 2-22-2021; operative 4/1/2021 (Register 2021, No. 9).